THE POTENTIAL DRUG-DRUG INTERACTIONS BETWEEN ANTIBIOTICS AND OTHER PRESCRIBED MEDICATIONS IN A TERTIARY CARE CENTRE
Main Article Content
Keywords
Antibiotics, Drug-drug Interactions, Polypharmacy, Antibiotic resistance
Abstract
Background: Antibiotics are among the most commonly prescribed drugs in clinical practice and are frequently co-prescribed with other medications various indications. This polypharmacy increases the risk of drug-drug interactions, which can lead to adverse drug events, treatment failure and increased healthcare costs. India being one of the top consumers of antibiotics, evaluating potential DDIs is crucial for optimizing patient safety.
Aims and Objectives: To assess the prevalence, severity, and clinical relevance of potential drug–drug interactions involving antimicrobial agents among adult patients in a tertiary care centre.
Methodology: A cross-sectional descriptive study was conducted at HIMS Teaching Hospital, Hassan. A total of 400 treatment charts and prescriptions of adult patients prescribed with antibiotics were reviewed. DDIs were identified using the Lexicomp and Medscape drug interaction databases and categorized by severity and analyzed with appropriate statistical tests.
Results: A total of 2,284 drugs were prescribed across 400 prescriptions, with an average of 5.71±1.62 drugs per patient and antibiotics accounted for 31.69% of prescriptions (31.69%). Lexicomp identified 68 potential DDIs, most of which were minor (Category C: 70.5%), followed by monitoring-required (D: 23.5%) and contraindicated (X: 16.1%) combinations. Medscape reported 142 potential DDIs: minor (69.95%), monitor closely (22.3%) and contraindicated (7.75%). No significant correlation was observed between the number of drugs per prescription and the number of DDIs. Ciprofloxacin, Doxycycline and Aminoglycosides were most frequently involved in interactions.
Conclusion: The study highlights the frequent occurrence of potential DDIs involving antibiotics, particularly fluoroquinolones and aminoglycosides. Lexicomp and Medscape databases showed significant variability in DDI detection, emphasizing the need for clinicians to use reliable drug interaction tools during prescribing. Continued pharmacovigilance and antibiotic stewardship are essential to reduce DDI-related risks in hospitalized patients.
References
2. Farooqui HH, Selvaraj S, Mehta A, Heymann DL. Community level antibiotic utilization in India and its comparison vis-a-vis European countries: Evidence from pharmaceutical sales data. PLoS One. 2018;13(10):e0204805.
3. Yimenu DK, Emam A, Elemineh E, Atalay W. Assessment of Antibiotic Prescribing Patterns at Outpatient Pharmacy Using World Health Organization Prescribing Indicators. J Prim Care Comm Heal. 2019;10:e886942.
4. Singh SK, Sengupta S, Antony R, Bhattacharya S, Mukhopadhyay C, Ramasubramanian V et al.Variations in antibiotic use across India: multi-centre study through Global Point Prevalence survey. J of Hos Inf. 2019;103(3): 280-83.
5. Guthrie B, Makubate B, Santiago VH. Dreischulte T.The rising tide of polypharmacy and drug-drug interactions: population database analysis1995–2010. BMC med 2015;13:74-8.
6. Krahenbuhl-Melcher A, Schlienger R, Lampert M. Drug-related problems in hospitals: A review of the recent literature. Drug Saf. 2007;30:379–407.
7. Pai MP, Momary KM, Rodvold KA. Antibiotic Drug Interactions. Med Clin N Am 2006;90:1223–55.
8. Shukla PK, Sharma P, Rawat P, Samar J, Moriwal R. Efficient prediction of drug drug interaction using deep learning models. IET Sys Biol. 2020;14(4);211-16.
9. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA.1998;279:1200–5.
10. Uijtendaal EV, van Harssel LL, Hugenholtz GW. Analysis of potential drug–drug interactions in medical intensive care unit patients. Pharm ther. 2014;34(3):213–19.
11. Kuscu F, Aslihan UA, Inal AS, Suntur BM, Aydemir H, Gul S et al. Potential Drug–Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study Med Sci Monit, 2018; 24: 4240-7.
12. Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9(6):364-77.
13. Zhao Y, Yin J, Zhang L, Zhang Y, Chen X. Drug-drug interaction prediction: databases, web servers and computational models. Brief Bioinform. 2023 :22;25(1):bbad445.
14. Xiong G, Yang Z, Yi J, Wang N, Wang L, Zhu H et al. DDInter: an online drug–drug interaction database towards improving clinical decision-making and patient safety. Nucleic Acids Res. 2022;50(D1):1200-207.
15. Bayuk BN, Dede I, Tazcan S Evaluation of Potential Drug Interactions with Proton Pump Inhibitors: A Retrospective Study. J lit pharm sci. 2023;12(1):1-7.
16. Bhattacharjee S, Mothsarab C, Shafiq N, Pandac PK, Rohillad R, Kaore SN. Antimicrobial prescription patterns in tertiary care centres in India: a multicentric point prevalence survey. eClin Med. 2025;82:103175.
17. Bade D, Murthy KG, Prasada LJ, Harish VS, Pradeep AN. A cross sectional study on prescription pattern of drugs in upper respiratory tract infections in a tertiary care hospital. Inter J of Basic & Clin Pharm. 2020: 9(2), 271-5.
18. Radkowski P, Derkaczew M, Mazuchowski M, Moussa A, Podhorodecka K, Dawidowska-Fidrych J, et al. Antibiotic-Drug Interactions in the Intensive Care Unit: A Literature Review. Antibiotic. 2024;13(6):503.
19. Shakeel F, Fang F, Kidwell KM, Marcath LA, Hertz DL. Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents. Journal of Oncology Pharmacy Practice. 2020;26(8):1843-9.
20. Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257-263.
21. Dookeeram D, Bidaisee S, Paul JF, Nunes P, Robertson P, Maharaj VR, et al. Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean. Int J Clin Pharm. 2017;39(5):1119-7
22. Corsonello A, Abbatecola AM, Fusco S, Luciani F, Marino A, Catalano S, et al. The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly. Clin Microbiol Infect. 2015 Jan;21(1):20-6.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Ganavi M V
Post graduate, Department of Pharmacology Hassan Institute of Medical Sciences, Hassan
Dr Jayashree V Nagaral
Assistant Professor, Department of Pharmacology Hassan Institute of Medical Sciences, Hassan
Dr Deepak P
Professor and Head, Department of Pharmacology Hassan Institute of Medical Sciences, Hassan
Dr Sahana G N
Associate Professor, Department of Pharmacology Hassan Institute of Medical Sciences, Hassan
Dr Vishali P
Post graduate student, Department of Pharmacology,Hassan Institute of Medical Sciences, Hassan
Dr Babitha L
Post graduate, Department of Pharmacology, Hassan Institute of Medical Sciences, Hassan